News from inspiremd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:NSPR)

Mar 16, 2015, 09:00 ET

InspireMD Plan of Compliance Accepted by NYSE MKT

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"),  announced today that...

Mar 12, 2015, 16:05 ET

InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced its...

Mar 09, 2015, 16:52 ET

InspireMD Announces Closing of Public Offering for Approximately $13.7 Million

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems ("EPS"), today announced the...

Mar 06, 2015, 11:30 ET

InspireMD to Report Financial Results for the Fourth Quarter and Year Ended December 31, 2014 on Thursday, March 12th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, announced today that it will...

Mar 04, 2015, 07:52 ET

InspireMD Announces Public Offering for Approximately $13.5 Million

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems ("EPS"), today announced that...

Mar 03, 2015, 16:15 ET

InspireMD Announces Proposed Public Offering of Common Stock and Warrants

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems ("EPS"), today announced that it...

Feb 26, 2015, 16:30 ET

InspireMD to Present at the Cowen and Company 35th Annual Healthcare Conference

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that its...

Jan 27, 2015, 08:30 ET

InspireMD Receives CE Mark Approval for Its New CGuard RX and Announces Positive Six Month Follow-Up CARENET Trial Data at LINC 2015

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it received...

Jan 21, 2015, 16:05 ET

InspireMD Announces Notification of NYSE MKT Listing Deficiency

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced the receipt...

Jan 13, 2015, 08:30 ET

InspireMD to Announce Positive Six Month Results from the CGuardTM CARENET Trial at LINC 2015

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that six...

Jan 05, 2015, 16:30 ET

InspireMD Pre-Announces a Fourth Quarter 2014 Revenue Increase of 200% Over the Third Quarter of 2014 and Provides Update on Corporate and Commercial Strategies

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today...

Dec 15, 2014, 08:30 ET

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced results from...

Nov 12, 2014, 16:11 ET

InspireMD Reports Financial Results for the Third Quarter ended September 30, 2014

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced its...

Nov 07, 2014, 17:20 ET

InspireMD Completes $8.1 Million Registered Direct Offering

InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in stent Embolic Protection Systems (EPS), today announced the...

Nov 05, 2014, 16:05 ET

InspireMD to Report Financial Results for the Third Quarter Ended September 30, 2014 on Wednesday, November 12th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems, announced today that it will...

Nov 04, 2014, 09:27 ET

InspireMD Announces Registered Direct Offering for Approximately $8 Million

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in stent Embolic Protection Systems (EPS), today announced that...

Oct 29, 2014, 09:06 ET

InspireMD Investigational Device Exemption (IDE) amendment approved by the FDA

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in Embolic Protection Systems (EPS), today announced that the...

Oct 14, 2014, 07:30 ET

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in stent Embolic Protection Systems (EPS), today provided...

Oct 01, 2014, 08:40 ET

InspireMD Announces Initial Commercial Sales of the CGuard™ EPS

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems (EPS), today announced that it...

Sep 18, 2014, 15:35 ET

InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), will host a live webinar and...